VFA
Virtus Fund Advisers Portfolio holdings
AUM
$32.1M
1-Year Return
39.5%
This Quarter Return
+4.75%
1 Year Return
+39.5%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$14.3B
AUM Growth
–
Cap. Flow
+$14.3B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
12.4%
Holding
2,847
New
2,843
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Cigna
CI
|
+$287M |
| 2 |
Ameriprise Financial
AMP
|
+$210M |
| 3 |
Steris
STE
|
+$193M |
| 4 |
NetApp
NTAP
|
+$186M |
| 5 |
T Rowe Price
TROW
|
+$183M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Industrials | 18.6% |
| 2 | Financials | 17.66% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Technology | 10.79% |
| 5 | Healthcare | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SQI
426
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $1.18M | 0.01% |
+66,624
| New | +$1.18M |
|
427
Church & Dwight Co
CHD
$22.7B
| $1.17M | 0.01% |
+33,370
| New | +$1.17M |
|
428
Altria Group
MO
$111B
| $1.16M | 0.01% |
+27,750
| New | +$1.16M |
|
429
Abbott
ABT
$225B
| $1.14M | 0.01% |
+27,891
| New | +$1.14M |
|
|
PSIX
430
Power Solutions International, Inc. Common Stock
PSIX
$2.06B
| $1.13M | 0.01% |
+15,694
| New | +$1.13M |
|
431
Financial Select Sector SPDR Fund
XLF
$53.9B
| $1.13M | 0.01% |
+56,375
| New | +$1.13M |
|
432
Bristol-Myers Squibb
BMY
$96B
| $1.12M | 0.01% |
+23,065
| New | +$1.12M |
|
433
3M
MMM
$81.8B
| $1.12M | 0.01% |
+9,329
| New | +$1.12M |
|
434
Signet Jewelers
SIG
$3.75B
| $1.12M | 0.01% |
+10,103
| New | +$1.12M |
|
435
Skyworks Solutions
SWKS
$10.9B
| $1.12M | 0.01% |
+23,784
| New | +$1.12M |
|
|
DD
436
DELISTED
Du Pont De Nemours E I
DD
| $1.11M | 0.01% |
+17,802
| New | +$1.11M |
|
|
ARNA
437
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.1M | 0.01% |
+18,777
| New | +$1.1M |
|
438
Anika Therapeutics
ANIK
$121M
| $1.1M | 0.01% |
+23,728
| New | +$1.1M |
|
439
HF Sinclair
DINO
$9.57B
| $1.1M | 0.01% |
+25,142
| New | +$1.1M |
|
440
Amgen
AMGN
$150B
| $1.08M | 0.01% |
+9,150
| New | +$1.08M |
|
441
AbbVie
ABBV
$374B
| $1.06M | 0.01% |
+18,853
| New | +$1.06M |
|
442
Universal Health Services
UHS
$11.8B
| $1.06M | 0.01% |
+11,050
| New | +$1.06M |
|
443
Ionis Pharmaceuticals
IONS
$10.2B
| $1.05M | 0.01% |
+30,431
| New | +$1.05M |
|
444
Neurocrine Biosciences
NBIX
$14B
| $1.05M | 0.01% |
+70,604
| New | +$1.05M |
|
445
Oceaneering
OII
$2.45B
| $1.04M | 0.01% |
+13,323
| New | +$1.04M |
|
446
MBIA
MBI
$374M
| $1.04M | 0.01% |
+94,000
| New | +$1.04M |
|
447
Sangamo Therapeutics
SGMO
$160M
| $1.04M | 0.01% |
+67,970
| New | +$1.04M |
|
448
Boeing
BA
$172B
| $1.03M | 0.01% |
+8,066
| New | +$1.03M |
|
449
Federal Realty Investment Trust
FRT
$8.67B
| $1.02M | 0.01% |
+8,425
| New | +$1.02M |
|
450
Health Care Select Sector SPDR Fund
XLV
$34B
| $1.02M | 0.01% |
+16,689
| New | +$1.02M |
|